Comments
Loading...

VYNE Therapeutics

VYNENASDAQ
Logo brought to you by Benzinga Data
$1.88
0.021.08%
Pre-Market: Sep 13, 7:12 PM EDT
15 minutes delayed

VYNE Therapeutics (NASDAQ:VYNE) Stock, Earnings Estimates, EPS, And Revenue

VYNE Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 11
EPS Estimate
$-0.230
Quarterly Revenue Estimate
$110K
Annual Revenue
(as of Jun 30)
$486K

Analyze the earnings history of VYNE Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

VYNE Therapeutics (VYNE) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-14$-0.22$-0.19-15.8 %
Mar 20242024-05-09$-0.15$-0.2437.5 %
Dec 20232024-02-29$-0.18$-0.5064.0 %
Sep 20232023-11-13$-1.75$-1.9711.2 %

VYNE Therapeutics (VYNE) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-14$198.00K$110.00K80.0 %
Mar 20242024-05-09$98.00K$100.00K-2.00 %
Dec 20232024-02-29$76.00K$150.00K-49.3 %
Jun 20232023-08-14$135.00K$100.00K35.0 %

FAQ

Q

When is VYNE Therapeutics (NASDAQ:VYNE) reporting earnings?

A

VYNE Therapeutics (VYNE) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on August 14, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for VYNE Therapeutics (NASDAQ:VYNE)?

A

The Actual EPS was $-0.22, which missed the estimate of $-0.19.

Q

What were VYNE Therapeutics’s (NASDAQ:VYNE) revenues?

A

The Actual Revenue was $198K, which beat the estimate of $110K.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch